Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-24

Clinical Trial Update: Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential drug interactions among HRS-1780, Henagliflozin, Metformin, and HRS-7535 completed in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-1780
  • HRS-7535 (HRS-7535)
  • Henagliflozin (henagliflozin)
  • metformin (metformin)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED